Renal cell carcinoma
Renal cell carcinoma
复制标题
DOI：
10.1007/s00120-011-2677-5
复制
发表时间：
2011-09-01
期刊：
影响因子：
--
通讯作者：
Hoda, M. R.
中科院分区：
文献类型：
--
作者：
Fornara, P.;Hoda, M. R.
大约85%的肾恶性肿瘤是肾细胞癌（RCC）。超声检查是早期发现肾脏肿瘤的主要检查方法。近年来，局部和转移性癌的新治疗方案丰富了RCC的治疗。碾压细胞癌的分类基于TNM和UICC标准。所谓的Motzer标准正越来越多地被用于评估预后和监测治疗，并作为决定选择全身治疗类型的基础。
Approximately 85% of all malignant tumors of the kidney are renal cell carcinomas (RCC). Sonography is the leading examination for early detection of kidney tumors. The treatment of RCC has been enriched in recent years by new therapeutic options for localized and metastatic cancer. The classification of RCC is based on TNM and UICC criteria. The so-called Motzer criteria are being increasingly employed to assess prognosis and monitor therapy and as the basis for reaching decisions on choosing the type of systemic treatment.